We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
38 result(s) found, displaying 31 to 38
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FYCOMPA perampanel (as hemisesquihydrate) 6 mg film coated tablet blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FYCOMPA perampanel (as hemisesquihydrate) 10 mg film coated tablet blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FYCOMPA perampanel (as hemisesquihydrate) 2 mg film coated tablet blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FYCOMPA perampanel (as hemisesquihydrate) 12 mg film coated tablet blister.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Lenvatinib mesilate
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial.
-
Cancellation for failure to pay annual chargeCancelled under s30(2)(f) of the Act
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Eribulin mesilate